
These 5 Latest Cancer Breakthroughs Are Improving Response Rates and Extending Lives
Here are some of the latest cancer breakthroughs in research, testing, and treatment.

Here are some of the latest cancer breakthroughs in research, testing, and treatment.

The platform is intended for use by dental professionals, dental service organisations, and imaging centres.

MannKind (Nasdaq:MNKD) announced today that it secured $50 million in a private placement and earned a new regulatory nod.

The brain is a vast, densely interconnected network of neurons computing in parallel. Watching these computations unfold in real time could reveal how the brain processes sensation and guides behavior. But the electrical signals governing the network are fast, faint and notoriously hard to capture in living tissue.

Predicting an individual’s risk of ischemic stroke is difficult because thrombosis embolization—the process of a blood clot detaching from the area where it formed, traveling and then sticking in another blood vessel—is based on factors unique to each person.

Momentis Surgical (formerly Memic) announced today that it received FDA 510(k) clearance for the multiport configuration of its surgical robot.

University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer.

Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting in Device, the handheld, smartphone-assisted device measures acetone—a molecule that is released into the breath when the body burns fat—in about 90 seconds with laboratory-level accuracy.

Implanted medical devices are instruments placed surgically in the body. Many are battery-powered or can be wirelessly recharged. While they can be lifesavers, they are not without problems. They can run out of battery power, and wireless methods for transferring power and data have technical limitations.

Clinical case study challenges established paradigms on permanent cognitive and motor decline in age-related degenerative diseases.